Annual CFF:
-$1.25B-$1.24B(-10444.54%)Summary
- As of today, UTHR annual cash from financing is -$1.25 billion, with the most recent change of -$1.24 billion (-10444.54%) on December 31, 2024.
- During the last 3 years, UTHR annual cash from financing has fallen by -$1.30 billion (-2900.89%).
- UTHR annual cash from financing is now -305.30% below its all-time high of $611.20 million, reached on December 31, 2019.
Performance
UTHR Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFF:
-$956.00M-$757.40M(-381.37%)Summary
- As of today, UTHR quarterly cash from financing is -$956.00 million, with the most recent change of -$757.40 million (-381.37%) on September 30, 2025.
- Over the past year, UTHR quarterly cash from financing has dropped by -$894.60 million (-1457.00%).
- UTHR quarterly cash from financing is now -218.16% below its all-time high of $809.10 million, reached on March 31, 2019.
Performance
UTHR Quarterly Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
-$1.32B-$894.60M(-208.77%)Summary
- As of today, UTHR TTM cash from financing is -$1.32 billion, with the most recent change of -$894.60 million (-208.77%) on September 30, 2025.
- Over the past year, UTHR TTM cash from financing has dropped by -$50.20 million (-3.94%).
- UTHR TTM cash from financing is now -262.94% below its all-time high of $812.00 million, reached on June 30, 2019.
Performance
UTHR TTM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
UTHR Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -10000.0% | -1457.0% | -3.9% |
| 3Y3 Years | -2900.9% | -10000.0% | -4928.8% |
| 5Y5 Years | -305.3% | -10000.0% | -664.8% |
UTHR Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -1764.2% | at low | -1617.5% | +10.5% | -1002.5% | at low |
| 5Y | 5-Year | -305.3% | at low | -1617.5% | +10.5% | -1002.5% | at low |
| All-Time | All-Time | -305.3% | at low | -218.2% | +10.5% | -262.9% | at low |
UTHR Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$956.00M(-381.4%) | -$1.32B(-208.8%) |
| Jun 2025 | - | -$198.60M(-111.7%) | -$428.50M(-54.2%) |
| Mar 2025 | - | -$93.80M(-25.6%) | -$277.90M(+77.8%) |
| Dec 2024 | -$1.25B(>-9900.0%) | -$74.70M(-21.7%) | -$1.25B(+1.6%) |
| Sep 2024 | - | -$61.40M(-27.9%) | -$1.27B(-5.7%) |
| Jun 2024 | - | -$48.00M(+95.5%) | -$1.20B(-6.4%) |
| Mar 2024 | - | -$1.07B(-1018.3%) | -$1.13B(-9405.9%) |
| Dec 2023 | -$11.90M(-115.8%) | -$95.50M(-1356.6%) | -$11.90M(-108.1%) |
| Sep 2023 | - | $7.60M(-69.2%) | $146.60M(+0.4%) |
| Jun 2023 | - | $24.70M(-51.9%) | $146.00M(+0.6%) |
| Mar 2023 | - | $51.30M(-18.6%) | $145.20M(+75.2%) |
| Dec 2022 | $75.40M(+68.3%) | $63.00M(+800.0%) | $82.90M(+202.6%) |
| Sep 2022 | - | $7.00M(-70.7%) | $27.40M(-25.9%) |
| Jun 2022 | - | $23.90M(+317.3%) | $37.00M(+56.1%) |
| Mar 2022 | - | -$11.00M(-246.7%) | $23.70M(-47.1%) |
| Dec 2021 | $44.80M(+365.1%) | $7.50M(-54.8%) | $44.80M(-0.7%) |
| Sep 2021 | - | $16.60M(+56.6%) | $45.10M(+32.3%) |
| Jun 2021 | - | $10.60M(+5.0%) | $34.10M(-24.4%) |
| Mar 2021 | - | $10.10M(+29.5%) | $45.10M(+396.7%) |
| Dec 2020 | -$16.90M(-102.8%) | $7.80M(+39.3%) | -$15.20M(+91.2%) |
| Sep 2020 | - | $5.60M(-74.1%) | -$173.00M(+23.8%) |
| Jun 2020 | - | $21.60M(+143.0%) | -$226.90M(+8.5%) |
| Mar 2020 | - | -$50.20M(+66.5%) | -$248.10M(-140.6%) |
| Dec 2019 | $611.20M(+9601.6%) | -$150.00M(-210.6%) | $611.20M(-19.7%) |
| Sep 2019 | - | -$48.30M(>-9900.0%) | $761.30M(-6.2%) |
| Jun 2019 | - | $400.00K(-100.0%) | $812.00M(+0.9%) |
| Mar 2019 | - | $809.10M(>+9900.0%) | $804.80M(>+9900.0%) |
| Dec 2018 | $6.30M(-85.5%) | $100.00K(-95.8%) | $6.30M(-21.3%) |
| Sep 2018 | - | $2.40M(+135.3%) | $8.00M(-12.1%) |
| Jun 2018 | - | -$6.80M(-164.2%) | $9.10M(-53.3%) |
| Mar 2018 | - | $10.60M(+488.9%) | $19.50M(-55.0%) |
| Dec 2017 | $43.30M(+108.7%) | $1.80M(-48.6%) | $43.30M(+171.9%) |
| Sep 2017 | - | $3.50M(-2.8%) | -$60.20M(+69.3%) |
| Jun 2017 | - | $3.60M(-89.5%) | -$196.00M(+42.4%) |
| Mar 2017 | - | $34.40M(+133.8%) | -$340.10M(+31.7%) |
| Dec 2016 | -$497.70M(-11.3%) | -$101.70M(+23.1%) | -$497.70M(-21.5%) |
| Sep 2016 | - | -$132.30M(+5.8%) | -$409.69M(-28.3%) |
| Jun 2016 | - | -$140.50M(-14.0%) | -$319.40M(+24.8%) |
| Mar 2016 | - | -$123.20M(-799.6%) | -$424.67M(+5.0%) |
| Dec 2015 | -$447.00M(+22.5%) | -$13.70M(+67.4%) | -$446.94M(+33.5%) |
| Sep 2015 | - | -$42.01M(+82.9%) | -$672.53M(+4.3%) |
| Jun 2015 | - | -$245.76M(-68.9%) | -$703.10M(-9.8%) |
| Mar 2015 | - | -$145.48M(+39.2%) | -$640.10M(-11.0%) |
| Dec 2014 | -$576.60M(>-9900.0%) | -$239.28M(-229.7%) | -$576.53M(-75.6%) |
| Sep 2014 | - | -$72.58M(+60.3%) | -$328.37M(-36.0%) |
| Jun 2014 | - | -$182.76M(-123.1%) | -$241.41M(-175.2%) |
| Mar 2014 | - | -$81.92M(-1021.9%) | -$87.73M(-1615.1%) |
| Dec 2013 | -$5.12M(+97.0%) | $8.89M(-38.2%) | -$5.12M(+92.0%) |
| Sep 2013 | - | $14.39M(+149.5%) | -$63.99M(+43.5%) |
| Jun 2013 | - | -$29.08M(-4290.6%) | -$113.33M(+33.6%) |
| Mar 2013 | - | $694.00K(+101.4%) | -$170.57M(-0.8%) |
| Dec 2012 | -$169.14M | -$49.99M(-43.0%) | -$169.14M(+54.0%) |
| Sep 2012 | - | -$34.95M(+59.5%) | -$367.67M(-10.6%) |
| Jun 2012 | - | -$86.33M(-4156.9%) | -$332.29M(-42.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | $2.13M(+100.9%) | -$233.90M(-7.3%) |
| Dec 2011 | -$218.08M(-248.6%) | -$248.51M(>-9900.0%) | -$218.08M(-331.9%) |
| Sep 2011 | - | $421.00K(-96.5%) | $94.04M(-11.1%) |
| Jun 2011 | - | $12.06M(-32.8%) | $105.81M(-10.0%) |
| Mar 2011 | - | $17.95M(-71.8%) | $117.62M(-19.9%) |
| Dec 2010 | $146.76M(+302.3%) | $63.60M(+421.5%) | $146.76M(+55.9%) |
| Sep 2010 | - | $12.20M(-48.9%) | $94.12M(-5.8%) |
| Jun 2010 | - | $23.87M(-49.3%) | $99.97M(+21.1%) |
| Mar 2010 | - | $47.09M(+329.2%) | $82.52M(+126.2%) |
| Dec 2009 | $36.48M(-82.9%) | $10.97M(-39.2%) | $36.48M(-80.0%) |
| Sep 2009 | - | $18.04M(+181.0%) | $181.98M(-5.6%) |
| Jun 2009 | - | $6.42M(+515.6%) | $192.79M(-4.2%) |
| Mar 2009 | - | $1.04M(-99.3%) | $201.22M(-5.5%) |
| Dec 2008 | $213.03M(+920.3%) | $156.47M(+442.3%) | $213.00M(+86.9%) |
| Sep 2008 | - | $28.86M(+94.3%) | $113.98M(+18.7%) |
| Jun 2008 | - | $14.85M(+15.8%) | $96.04M(+6.2%) |
| Mar 2008 | - | $12.82M(-77.7%) | $90.43M(+333.1%) |
| Dec 2007 | $20.88M(-71.8%) | $57.46M(+426.5%) | $20.88M(-69.3%) |
| Sep 2007 | - | $10.91M(+18.1%) | $68.09M(+229.8%) |
| Jun 2007 | - | $9.24M(+116.3%) | $20.65M(+48.8%) |
| Mar 2007 | - | -$56.73M(-154.2%) | $13.87M(-81.3%) |
| Dec 2006 | $74.13M(+423.1%) | $104.67M(+386.5%) | $74.13M(+371.8%) |
| Sep 2006 | - | -$36.53M(-1584.6%) | -$27.28M(-290.3%) |
| Jun 2006 | - | $2.46M(-30.3%) | $14.33M(-6.0%) |
| Mar 2006 | - | $3.53M(+8.1%) | $15.24M(+7.6%) |
| Dec 2005 | $14.17M(+124.4%) | $3.27M(-35.6%) | $14.17M(+5.5%) |
| Sep 2005 | - | $5.07M(+50.7%) | $13.43M(+17.9%) |
| Jun 2005 | - | $3.37M(+36.9%) | $11.39M(+28.3%) |
| Mar 2005 | - | $2.46M(-2.7%) | $8.88M(+40.6%) |
| Dec 2004 | $6.32M(+214.7%) | $2.53M(-16.6%) | $6.32M(+176.2%) |
| Sep 2004 | - | $3.03M(+253.8%) | $2.29M(+418.6%) |
| Jun 2004 | - | $857.00K(+940.2%) | $441.00K(-76.9%) |
| Mar 2004 | - | -$102.00K(+93.2%) | $1.91M(-4.9%) |
| Dec 2003 | $2.01M(+984.9%) | -$1.50M(-226.5%) | $2.01M(-43.2%) |
| Sep 2003 | - | $1.19M(-49.0%) | $3.53M(+39.7%) |
| Jun 2003 | - | $2.32M(>+9900.0%) | $2.53M(+1152.0%) |
| Mar 2003 | - | -$3000.00(-112.0%) | $202.00K(+9.2%) |
| Dec 2002 | $185.00K(+106.4%) | $25.00K(-86.3%) | $185.00K(+36.0%) |
| Sep 2002 | - | $183.00K(+6200.0%) | $136.00K(+133.2%) |
| Jun 2002 | - | -$3000.00(+85.0%) | -$410.00K(+78.3%) |
| Mar 2002 | - | -$20.00K(+16.7%) | -$1.89M(+34.4%) |
| Dec 2001 | -$2.88M(-101.4%) | -$24.00K(+93.4%) | -$2.88M(+58.6%) |
| Sep 2001 | - | -$363.00K(+75.6%) | -$6.96M(-105.4%) |
| Jun 2001 | - | -$1.49M(-47.0%) | $127.82M(-2.1%) |
| Mar 2001 | - | -$1.01M(+75.4%) | $130.60M(-36.8%) |
| Dec 2000 | $206.61M(+248.4%) | -$4.10M(-103.1%) | $206.61M(-1.7%) |
| Sep 2000 | - | $134.41M(>+9900.0%) | $210.12M(+149.3%) |
| Jun 2000 | - | $1.30M(-98.3%) | $84.28M(-36.4%) |
| Mar 2000 | - | $75.00M(>+9900.0%) | $132.48M(+123.6%) |
| Dec 1999 | $59.30M(+159.0%) | -$596.60K(-107.0%) | $59.26M(-1.0%) |
| Sep 1999 | - | $8.58M(-82.7%) | $59.86M(+16.7%) |
| Jun 1999 | - | $49.49M(+2668.2%) | $51.28M(+2768.2%) |
| Mar 1999 | - | $1.79M | $1.79M |
| Dec 1998 | $22.90M | - | - |
FAQ
- What is United Therapeutics Corporation annual cash from financing?
- What is the all-time high annual cash from financing for United Therapeutics Corporation?
- What is United Therapeutics Corporation annual cash from financing year-on-year change?
- What is United Therapeutics Corporation quarterly cash from financing?
- What is the all-time high quarterly cash from financing for United Therapeutics Corporation?
- What is United Therapeutics Corporation quarterly cash from financing year-on-year change?
- What is United Therapeutics Corporation TTM cash from financing?
- What is the all-time high TTM cash from financing for United Therapeutics Corporation?
- What is United Therapeutics Corporation TTM cash from financing year-on-year change?
What is United Therapeutics Corporation annual cash from financing?
The current annual cash from financing of UTHR is -$1.25B
What is the all-time high annual cash from financing for United Therapeutics Corporation?
United Therapeutics Corporation all-time high annual cash from financing is $611.20M
What is United Therapeutics Corporation annual cash from financing year-on-year change?
Over the past year, UTHR annual cash from financing has changed by -$1.24B (-10444.54%)
What is United Therapeutics Corporation quarterly cash from financing?
The current quarterly cash from financing of UTHR is -$956.00M
What is the all-time high quarterly cash from financing for United Therapeutics Corporation?
United Therapeutics Corporation all-time high quarterly cash from financing is $809.10M
What is United Therapeutics Corporation quarterly cash from financing year-on-year change?
Over the past year, UTHR quarterly cash from financing has changed by -$894.60M (-1457.00%)
What is United Therapeutics Corporation TTM cash from financing?
The current TTM cash from financing of UTHR is -$1.32B
What is the all-time high TTM cash from financing for United Therapeutics Corporation?
United Therapeutics Corporation all-time high TTM cash from financing is $812.00M
What is United Therapeutics Corporation TTM cash from financing year-on-year change?
Over the past year, UTHR TTM cash from financing has changed by -$50.20M (-3.94%)